comprehensive
Previous article:
Peter Hotez and the public health issue of online harassment
Next article: With trial win, GSK could get blood cancer drug back on market
Next article: With trial win, GSK could get blood cancer drug back on market
knowledge
focus
-
Do more moles mean more problems? Not so, says new study
2025-09-30 21:57 -
ASCO Daily Recap: Safety data from Novartis, survival from Pfizer
2025-09-30 20:48 -
Ultragenyx gene therapy for rare liver ailment succeeds in late
2025-09-30 20:36 -
Change Healthcare can notify patients about the breach, HHS says
2025-09-30 20:22 -
See how much Covid
2025-09-30 19:41 -
At ASCO, pharma leaders speak of advances in 'smart bomb' drugs
2025-09-30 19:27